Cinctive Capital Management LP acquired a new stake in shares of Herbalife Ltd (NYSE:HLF – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 92,138 shares of the company’s stock, valued at approximately $778,000. Cinctive Capital Management LP owned 0.09% of Herbalife at the end of the most recent quarter.
A number of other large investors have also bought and sold shares of HLF. Aster Capital Management DIFC Ltd bought a new position in shares of Herbalife during the 3rd quarter worth $35,000. GAMMA Investing LLC raised its stake in Herbalife by 115.6% in the 3rd quarter. GAMMA Investing LLC now owns 7,024 shares of the company’s stock valued at $59,000 after acquiring an additional 3,766 shares during the period. CHICAGO TRUST Co NA purchased a new stake in Herbalife during the third quarter valued at about $100,000. EMC Capital Management purchased a new stake in Herbalife during the second quarter valued at about $109,000. Finally, Lazard Asset Management LLC boosted its position in Herbalife by 30.4% during the third quarter. Lazard Asset Management LLC now owns 13,346 shares of the company’s stock worth $113,000 after purchasing an additional 3,112 shares during the period.
Herbalife Stock Down 0.7%
HLF stock opened at $15.28 on Tuesday. The stock has a 50-day simple moving average of $16.80 and a two-hundred day simple moving average of $12.66. Herbalife Ltd has a twelve month low of $6.20 and a twelve month high of $20.40. The firm has a market capitalization of $1.58 billion, a PE ratio of 6.94, a PEG ratio of 0.92 and a beta of 0.83.
Analyst Upgrades and Downgrades
Several equities analysts have recently weighed in on HLF shares. Argus set a $15.00 target price on shares of Herbalife in a research note on Wednesday, November 26th. Citigroup restated a “buy” rating and set a $21.00 price target (up from $17.00) on shares of Herbalife in a research note on Thursday, February 19th. Zacks Research raised shares of Herbalife from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 19th. Maxim Group began coverage on shares of Herbalife in a research note on Tuesday, January 6th. They issued a “buy” rating and a $20.00 price objective for the company. Finally, Mizuho set a $13.00 target price on shares of Herbalife and gave the company a “neutral” rating in a report on Thursday, January 8th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $16.60.
Get Our Latest Stock Analysis on Herbalife
Herbalife Profile
Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.
Founded in 1980 by Mark R.
Recommended Stories
- Five stocks we like better than Herbalife
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Herbalife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife and related companies with MarketBeat.com's FREE daily email newsletter.
